Editorial Board
Roy Gerona PhD
University of California, San Francisco · United States
Editorial leadership for Journal of Experimental and Clinical Toxicology ISSN 2641-7669
Research interests
- Analytical Toxicology Clinical Toxicology Novel Psychoactive Substances (Designer Drugs) Metabolic Profiling Of Designer Drugs
Biography
- Dr. Gerona received his Ph.D. in Biochemistry from the University of Wisconsin, Madison where he worked on synaptic vesicles and large dense core vesicle exocytosis with Thomas Martin.
- He then trained as Post-Doctoral Fellow with Alan Wu at San Francisco General Hospital- University of California, San Francisco under a COMACC- accredited program in Clinical Chemistry and Pharmacogenomics.
- Dr. Gerona's work during his fellowship focused on the clinical applications of liquid chromatography-time-of-flight mass spectrometry with emphasis on developing methods to support emergency intoxication testing.
- He is continuing this work, currently focusing on the analysis of novel psychoactive substances (NPS) intoxications through his collaborations with various Poison Control Centers, the Drug Enforcement Administration, and the Department of Homeland Security.
- Dr. Gerona runs the Clinical Toxicology and Environmental Biomonitoring Laboratory and the HIV and TB Hair Analysis Laboratory at UCSF.
- His laboratory also serves as the analytical core for the Program on Reproductive Health and the Environment (PRHE). Through collaborative work with various medical toxicologists, pharmacists, pharmacologists, chemists, and public health experts, Dr. Gerona's laboratory has been analyzing biological samples obtained from suspected NPS cases across the United States in the last five years.
- His laboratory has also actively conducted collaborative studies on a variety of toxicology-related subjects including surveillance studies on NPS use in raves and electronic dance festivals, surveillance of drugs of abuse in trauma cases, cross-reactivity of designer drugs with immunoassay screens for common drugs of abuse, stability of various prescription and designer drugs, occupational exposure to synthetic cannabinoids, and quantitative analysis of "research chemicals" obtained through the internet among others.
- Most recently his laboratory has started collaborative work on the pharmacological characterization of synthetic cannabinoids associated with acute intoxications along with "prophetic" structures that may have cannabimimetic properties.
Selected publications
- Development and validation of an LC-MS/MS assay for the quantitative analysis of alprazolam, α-hydroxyalprazolam and hydrocodone in dried blood spots 2023 cited 8×
- Organophosphate and organohalogen flame-retardant exposure and thyroid hormone disruption in a cohort of female firefighters and office workers from San Francisco 2020 cited 1×
- A direct LC–MS/MS method for simultaneous quantitation of bisphenol S, propylparaben, monobutyl phthalate, and their metabolites in human urine Recent 2026
- A direct LC–MS/MS method for simultaneous quantitation of bisphenol S, propylparaben, monobutyl phthalate, and their metabolites in human urine Recent 2026
- A direct LC–MS/MS method for simultaneous quantitation of bisphenol S, propylparaben, monobutyl phthalate, and their metabolites in human urine Recent 2026
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JECT for your work?
This journal is guided by Roy Gerona (University of California, San Francisco) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.